Third quarter of 2016 in brief · Order intake decreased 3.0% to SEK 7,176 M (7,397). The order intake declined organically by 3.2%. · Net sales increased 0.1% to SEK 6,929 M (6,925). Net sales increased organically by 0.2%. · Gross margin increased to 47.3% (46.8). · EBITA* improved 16.3% to SEK 963 M (828). · Restructuring costs increased to SEK 732 M (213). SEK 628 M comprises a provision for the FDA-related remediation program, write-down of an R&D project and costs for changes among senior executives. · Profit before tax decreased 146.2% to SEK -110 M (238), due to increased restructuring costs. · Earnings per share decreased to SEK -0.36 (0.73). · Good cost control as a consequence of the efficiency-enhancement program, Big 5. · Changes to Getinge Executive Team, Acting CEO, new CFO and HR Director. · FDA update, SEK 400 M provision related to the remediation program. · Changed outlook, moderately negative sales growth for the full year. · Key event after the reporting period, further developed and focused strategy, and preparation for distribution of Patient & Post-Acute Care to shareholders of Getinge. January-September 2016 in brief · Order intake decreased 2.5% to SEK 21,560 M (22,105). The order intake fell organically by 0.7%. · Net sales decreased 2.8% to SEK 20,233 M (20,818). Net sales fell organically by 1.1%. · Gross margin amounted to 46.7% (46.7). · EBITA* improved 4.9% to SEK 2,371 M (2,260). · Restructuring costs increased to SEK 992 M (483). · Profit before tax decreased 42.8% to SEK 358 M (626). · Earnings per share decreased to SEK 1.03 (1.81). Financial summary MSEK Q3 Q3 Change Jan-Sep Jan-Sep 2015 Change % FY2015 2016 2015 % 2016 Order intake 7 176 7 397 -3.0% 21 560 22 105 -2.5% 30 431 Net sales 6 929 6 925 0.1% 20 233 20 818 -2.8% 30 235 Gross Profit 3 275 3 240 1.1% 9 453 9 713 -2.7% 14 163 Gross margin 47.3% 46.8% 0.5% 46.7% 46.7% 0.0% 46.8% EBITA* 963 828 16.3% 2 371 2 260 4.9% 4 179 EBITA 13.9% 12.0% 1.9% 11.7% 10.9% 0.8% 13.8% margin* Operating 49 421 -88.4% 838 1 184 -29.2% 2 729 profit Profit -110 238 -146.2% 358 626 -42.8% 1 997 before tax Net profit -81 174 -146.6% 261 457 -42.9% 1 457 Earnings per -0.36 0.73 -149.3% 1.03 1.81 -43.1% 5.83 share, SEK Cash flow 724 0.1% 1 888 1 974 -4.4% 3 458 from 725 operations * before restructuring, acquisition and integration cost For further information, please contact: Kornelia Rasmussen Executive Vice President Group Communications Phone: +46 (0)10 335 58 10 E-mail: kornelia.rasmussen@getinge.com Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care and for life science companies and institutions. Getinge’s unique customer offering mirrors the hospital’s organization and value chain, and the solutions are used before, during and after the patients’ hospital stay. Based on first -hand experience and close partnerships, Getinge provides innovative healthcare solutions that improve every-day life for people, today and tomorrow. This information is information that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 13:00 p.m. CET on October 18, 2016
Getinge Interim Report January-September 2016 Third quarter
Top 10 Most Recent News Articles
Duke Energy's Cost-Protection Plan Shields Ratepayers
Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...
Continue Reading
Wally Disrupts Dental Industry with $25M Funding
A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...
Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned
OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...
Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway
Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...
Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars
What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...
Continue Reading
Merit Expands in New York with Bold Acquisition Move
Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...
Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims
A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...
Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts
Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...
Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions
Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....
Continue Reading
EMCO's New Automated Facility Could Shake Industry
A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...
Continue ReadingTop 5 Most Recently Viewed Articles
Understanding Shareholder Rights for Fluor Corporation Investors
Important Notice for Fluor Corporation Shareholders The Gross Law Firm is reaching out to shareholders of Fluor Corporation (NYSE: FLR) with a timely update. Shareholders who purchased shares during the recently identified class period are encouraged to engage with the firm about potential legal rights and remedies. It is crucial to act quickly as the deadline for class...
Continue Reading
CARGO Therapeutics Merger Investigation: Shareholders Take Note
Understanding the CARGO Therapeutics Merger In a recent development, attorney Juan Monteverde is looking into the merger involving CARGO Therapeutics, Inc. (NASDAQ: CRGX). This merger is particularly significant as it involves Concentra Biosciences, LLC, which proposes to acquire CARGO for $4.379 in cash per share. Additionally, shareholders will gain a non-transferable...
Continue Reading
Veralto Declares Consistent Quarterly Dividend for Investors
Veralto's Quarterly Dividend Announcement Veralto (NYSE: VLTO), a leading name in water and product quality solutions, has announced a quarterly dividend of $0.09 per share. This decision underscores Veralto's unwavering commitment to its shareholders and its ongoing financial health. Understanding Dividend Payments Dividends often indicate a company's financial...
Continue Reading
Swvl Partners with G4S for Advanced Mobility Solutions in Saudi Arabia
Swvl Partners for Fleet Efficiency Swvl Holdings Corp, a prominent provider of technology-driven mobility solutions, has recently secured a three-year contract with G4S, a leading facility management company. This collaboration is set to revolutionize fleet operations in Saudi Arabia, marking an important milestone in Swvl's efforts to expand its SaaS-based offerings....
Continue Reading
Boliden AB Reports Significant Increase in Share Capital
Boliden AB Reports Substantial Increase in Share Capital Boliden AB, well-regarded in the minerals and metallurgy sector, recently reported a considerable boost to its number of shares and overall share capital. This increase follows the company's successful directed share issue of 10,714,285 shares, which also equates to a corresponding increase in voting rights. Details...
Continue Reading